To address the impact of pharmacological inhibition of LIPG enzymatic function by XEN445 on TNBC tumor growth in vivo, we performed XEN445 therapy (50 mg/kg) on nude mice with MDA-MB-468 xenograft tumors. The gene discussed is LIPG; the disease is neoplasm.